Dark

Check out our Level2View

ISO
IsoPlexis Corporation Common Stock
stock NASDAQ

Inactive

Mar 20, 2023

0.7616USD+2.780%(+0.0206)111,019

Pre-market

0.00USD-100.000%(-0.74)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 27, 2022

01:01PM EST Where IsoPlexis Stands With Analysts Benzinga

04:34AM EST SVB Leerink Maintains Outperform on IsoPlexis, Lowers Price Target to $15 Benzinga

Jan 9, 2022

10:14PM EST IsoPlexis (ISO) said that it expects total revenue for 2021 to be in the range of $17.0 million to $17.2 million, representing an increase of approximately 64% to 66% compared to $10.4 million for the full year 2020. RTTNews

07:00PM EST IsoPlexis (NASDAQ:ISO), the Superhuman Cell Company, today announcedits preliminary unaudited revenue for the full year 2021. Total revenue for 2021 is expected to be in the range of $17.0 to $17.2 million, representing an increase of approximately 64% to 66% compared to $10.4 million for the full year 2020. GlobeNewswire Inc

Dec 29, 2021

06:03AM EST IsoEnergy Announces TSXV Approval Of Consolidated Uranium Option To Acquire Mountain Lake Property RTTNews

Dec 8, 2021

07:01AM EST IsoPlexis to Present IsoLight(r) Single-Cell Proteomics Data at ASH 2021 PR Newswire

Nov 30, 2021

07:01AM EST IsoPlexis Appoints Key Financial and Legal Hires from Leading Tools and Omics PR Newswire

Nov 24, 2021

07:01AM EST IsoPlexis to Participate in the Evercore ISI HealthCONx Conference PR Newswire

Nov 19, 2021

11:53AM EST Analyst Ratings For IsoPlexis Benzinga

10:09AM EST Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021 Benzinga

07:10AM EST Evercore ISI Group Initiates Coverage On IsoPlexis with Outperform Rating, Announces Price Target of $24 Benzinga

Nov 18, 2021

07:01AM EST IsoPlexis' Expanded Cell Therapy Offerings Demonstrated in Nature Medicine PR Newswire

Nov 12, 2021

07:01AM EST IsoPlexis Bolsters Its Global Operational and Product Support Leadership PR Newswire

Nov 11, 2021

05:13AM EST SVB Leerink Maintains Outperform on IsoPlexis, Raises Price Target to $20 Benzinga

Nov 10, 2021

08:47AM EST IsoPlexis Q3 Revenue Of $4.2 Mln, Increase Of 28% From Last Year RTTNews

08:44AM EST IsoPlexis Q3 Sales $4.20M Beat $3.80M Estimate Benzinga

08:41AM EST IsoPlexis Reports Third Quarter 2021 Financial Results PR Newswire

04:09AM EST Earnings Scheduled For November 10, 2021 Benzinga

Nov 5, 2021

07:01AM EDT IsoPlexis to Present Data at SITC 2021 Connecting Genetic Drivers to Functional PR Newswire

Nov 2, 2021

11:11AM EDT Benzinga's Top Ratings Upgrades, Downgrades For November 2, 2021 Benzinga

10:52AM EDT SVB Leerink Initiates Coverage On IsoPlexis with Outperform Rating, Announces Price Target of $17 Benzinga

10:48AM EDT Cowen & Co. Initiates Coverage On IsoPlexis with Outperform Rating Benzinga

10:43AM EDT Morgan Stanley Initiates Coverage On IsoPlexis with Overweight Rating, Announces Price Target of $16 Benzinga

Oct 31, 2021

02:24PM EDT The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline Benzinga

Oct 26, 2021

07:01AM EDT IsoPlexis to Report Third Quarter Financial Results on November 10, 2021 PR Newswire

Oct 12, 2021

04:06PM EDT IsoPlexis Announces Closing of Public Offering PR Newswire

02:06PM EDT IIROC Trading Resumption - ISO PR Newswire

01:44PM EDT IIROC Trading Halt - ISO PR Newswire

08:13AM EDT The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology Benzinga

Oct 8, 2021

11:11AM EDT IsoPlexis Shares Open For Trade At $14.75; IPO Priced At $15/Share Benzinga

10:37AM EDT IsoPlexis Indicating $15; IPO Priced At $15/Share Benzinga

09:26AM EDT IsoPlexis Shares Will Open For Quote At 10:10 a.m. EDT, Expected To Open For Trade After 10:20 a.m. EDT; IPO Priced At $15/Share Benzinga

Oct 7, 2021

11:28PM EDT IsoPlexis Corp. said it has priced its initial public offering of about 8.33 million shares of common stock at $15.00 per share. RTTNews

06:13PM EDT IsoPlexis Announces Pricing of Initial Public Offering PR Newswire

Share